Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical pharmacokinetics of cabergoline.
Del Dotto P, Bonuccelli U. Del Dotto P, et al. Clin Pharmacokinet. 2003;42(7):633-45. doi: 10.2165/00003088-200342070-00003. Clin Pharmacokinet. 2003. PMID: 12844325 Review.
Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
Del Dotto P, Gambaccini G, Caneparo D, Berti C, Bernardini S, Bonuccelli U. Del Dotto P, et al. Neurol Sci. 2003 Oct;24(3):170-1. doi: 10.1007/s10072-003-0114-2. Neurol Sci. 2003. PMID: 14598071
Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
Lucetti C, Del Dotto P, Gambaccini G, Bernardini S, Bianchi MC, Tosetti M, Bonuccelli U. Lucetti C, et al. Among authors: del dotto p. Neurol Sci. 2001 Feb;22(1):69-70. doi: 10.1007/s100720170051. Neurol Sci. 2001. PMID: 11487206
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study.
Del Dotto P, Pavese N, Gambaccini G, Bernardini S, Metman LV, Chase TN, Bonuccelli U. Del Dotto P, et al. Mov Disord. 2001 May;16(3):515-20. doi: 10.1002/mds.1112. Mov Disord. 2001. PMID: 11391748 Clinical Trial.
Diurnal motor variations to repeated doses of levodopa in Parkinson's disease.
Bonuccelli U, Del Dotto P, Lucetti C, Petrozzi L, Bernardini S, Gambaccini G, Rossi G, Piccini P. Bonuccelli U, et al. Among authors: del dotto p. Clin Neuropharmacol. 2000 Jan-Feb;23(1):28-33. doi: 10.1097/00002826-200001000-00006. Clin Neuropharmacol. 2000. PMID: 10682228 Clinical Trial.
Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease.
Napolitano A, Del Dotto P, Petrozzi L, Dell'Agnello G, Bellini G, Gambaccini G, Bonuccelli U. Napolitano A, et al. Among authors: del dotto p. Clin Neuropharmacol. 1999 Jan-Feb;22(1):24-9. doi: 10.1097/00002826-199901000-00005. Clin Neuropharmacol. 1999. PMID: 10047930
Clozapine in Parkinson's disease tremor. Effects of acute and chronic administration.
Bonuccelli U, Ceravolo R, Salvetti S, D'Avino C, Del Dotto P, Rossi G, Murri L. Bonuccelli U, et al. Among authors: del dotto p. Neurology. 1997 Dec;49(6):1587-90. doi: 10.1212/wnl.49.6.1587. Neurology. 1997. PMID: 9409351 Clinical Trial.
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease.
Del Dotto P, Colzi A, Musatti E, Strolin Benedetti M, Persiani S, Fariello R, Bonuccelli U. Del Dotto P, et al. Clin Neuropharmacol. 1997 Oct;20(5):455-65. doi: 10.1097/00002826-199710000-00011. Clin Neuropharmacol. 1997. PMID: 9331523 Clinical Trial.
Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patients.
Del Dotto P, Colzi A, Pardini C, Lucetti C, Dubini A, Grimaldi R, Bonuccelli U. Del Dotto P, et al. J Neural Transm Suppl. 1995;45:259-65. J Neural Transm Suppl. 1995. PMID: 8748633
Apomorphine test for dopaminergic responsiveness: a dose assessment study.
Bonuccelli U, Piccini P, Del Dotto P, Rossi G, Corsini GU, Muratorio A. Bonuccelli U, et al. Among authors: del dotto p. Mov Disord. 1993 Apr;8(2):158-64. doi: 10.1002/mds.870080207. Mov Disord. 1993. PMID: 8474482 Clinical Trial.
67 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page